on Saturday said its consolidated profit after tax declined 26 per cent to Rs 173 crore for the fourth quarter ended March 31, 2022. The company had reported a profit after tax (PAT) of Rs 234 crore in the January-March period of 2020-21…
Glenmark Pharmaceuticals on Saturday said its consolidated profit after tax declined 26 per cent to Rs 173 crore for the fourth quarter ended March 31, 2022. The company had reported a profit after tax (PAT) of Rs 234 crore in the…
NEW DELHI: Some of the major pharma stocks traded with cuts on Wednesday after reports said companies like Dr Reddy’s Labs, Glenmark, Mylan, Ipca Labs and Aurobindo are under GST intelligence investigation.
Reports said irregularities…
The company’s fully-owned unit Glenmark Specialty SA (Switzerland) has received approval from the USFDA for its new drug application (NDA) for Ryaltris, a fixed-dose (metered), prescription, combination nasal spray, Glenmark Pharmaceuticals…
Glenmark Pharmaceuticals has signed a partnership with Canandian company SaNOtize Research & Development Corp., to manufacture, market and distribute Nitric Oxide Nasal Spray (NONS) for COVID-19 treatment. According to Glenmark, NONS…